Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different doses of alfentanil combined with etomidate for general anesthesia induction in elderly patients
ChiCTR2300076661Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern War Zone of the Chinese People's Liberation Army
- Start
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of alfentanil and etomidate (3 arms), sponsored by General Hospital of the Northern War Zone of the Chinese People's Liberation Army. Primary endpoints: Mean arterial pressure changes after administration, Heart rate and 6 more. Planned start Oct 2023; status: not yet recruiting.
02
Drugs
alfentaniletomidate
Beyond the preview
Go deeper on ChiCTR2300076661.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076661.